Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • REGENERON PHARMACEUTICALS Analyst Recommendations

  • Analyst Consensus: REGN

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.400 Buy 10
    30 Days Ago 2.300 Buy 10
    60 Days Ago 2.300 Buy 10
    90 Days Ago 2.300 Buy 10
    120 Days Ago 2.300 Buy 10

  • Analyst Ratings: REGN

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    RBC Capital Mkts Outperform Sector Perform 10/29/2009 —
    ThinkEquity — Accumulate 05/04/2009 21.00
    Credit Suisse Neutral Outperform 05/01/2009 —
    Piper Jaffray Neutral Buy 03/30/2009 —
    RBC Capital Mkts — Outperform 02/27/2009 25.00
    Merriman Curhan Ford — Buy 10/23/2008 —
    Robert W. Baird — Neutral 09/23/2008 25.00
    Boenning & Scattergood — Market Outperform 08/26/2008 —
    Credit Suisse Outperform Neutral 06/05/2008 —
    Caris & Company Above Average — 03/13/2008 —
    Caris & Company Average Above Average 12/03/2007 23.00
    Canaccord Adams — Buy 11/02/2007 31.30
    RBC Capital Mkts — Outperform 05/03/2007 32.00
    Caris & Company — Average 01/31/2007 —
    Needham & Co — Buy 11/08/2006 29.00
    Credit Suisse — Outperform 11/06/2006 32.00
    Lehman Brothers — Overweight 10/19/2006 33.00
    RBC Capital Mkts — Outperform 10/19/2006 25.00
    RBC Capital Mkts — Outperform 07/27/2006 18.00
    Needham & Co — Buy 04/24/2006 22.00
    Lehman Brothers Equal-weight Overweight 12/27/2005 19.00
    Morgan Stanley Equal-weight Overweight 10/24/2005 16.00
    Adams Harkness — Mkt Perform 04/14/2005 —
    Banc of America Sec Neutral Sell 01/11/2005 —
    Morgan Stanley — Equal-weight 07/28/2004 12.00
    Banc of America Sec Buy Neutral 01/12/2004 —
    Morgan Stanley Underweight Equal-weight 06/10/2003 —
    Banc of America Sec Neutral Buy 06/09/2003 26.00
    JP Morgan Overweight Neutral 03/31/2003 —
    SG Cowen — Mkt Perform 03/17/2003 —
    Next